Kidney Failure
📧 Sign up to get email alerts when something new happens for Kidney Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2022-08-31Clinical Trial Update: HCV + to HCV - Kidney Transplant [Phase 4]
A Phase 4 clinical trial involving Hepatitis C and kidney failure in the context of kidney transplant was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-04-28Clinical Trial Update: High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy [Phase 4]
A Phase 4 trial comparing high versus low bicarbonate bath in critically ill patients on continuous renal replacement therapy was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-06-03Clinical Trial Update: Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant [Phase 4]
A Phase 4 clinical trial evaluating direct-acting antiviral therapy for donor HCV-positive to recipient HCV-negative kidney transplants has …
-
CLINICAL_TRIALS withdrawal · 2017-05-05Clinical Trial Update: Does Terlipressin Improve Renal Outcome After Liver Surgery [Phase 2]
A Phase 2 trial evaluating terlipressin to improve renal outcome after liver surgery was withdrawn.
-
EMA withdrawal · 2010-03-22EMA Application withdrawn: Ratioepo (epoetin theta) — Ratiopharm GmbH
EMA withdrew the application for Ratioepo (epoetin theta) by Ratiopharm GmbH for anemia-related indications.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2008-01-17Clinical Trial Update: Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)
The ACE polymorphism and acute renal failure trial (ECAREA) sponsored by University Hospital, Caen has been terminated.